|
1
|
Lutsenko S, Roy S and Tsvetkov P:
Mammalian copper homeostasis: Physiological roles and molecular
mechanisms. Physiol Rev. 105:441–491. 2025. View Article : Google Scholar :
|
|
2
|
Locatelli M and Farina C: Role of copper
in central nervous system physiology and pathology. Neural Regen
Res. 20:1058–1068. 2025. View Article : Google Scholar
|
|
3
|
Chen G, Li J, Han H, Du R and Wang X:
Physiological and molecular mechanisms of plant responses to copper
stress. Int J Mol Sci. 23:129502022. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Verdejo-Torres O, Klein DC, Novoa-Aponte
L, Carrazco-Carrillo J, Bonilla-Pinto D, Rivera A, Bakhshian A,
Fitisemanu FM, Jiménez-González ML, Flinn L, et al: Cysteine rich
intestinal protein 2 is a copper-responsive regulator of skeletal
muscle differentiation and metal homeostasis. PLoS Genet.
20:e10114952024. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen L, Min J and Wang F: Copper
homeostasis and cuproptosis in health and disease. Signal Transduct
Target Ther. 7:3782022. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Guo Z, Chen D, Yao L, Sun Y, Li D, Le J,
Dian Y, Zeng F, Chen X and Deng G: The molecular mechanism and
therapeutic landscape of copper and cuproptosis in cancer. Signal
Transduct Target Ther. 10:1492025. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang Y, Wu J, Wang L, Ji G and Dang Y:
Copper homeostasis and cuproptosis in health and disease. MedComm
(2020). 5:e7242024. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Myint ZW, Oo TH, Thein KZ, Tun AM and
Saeed H: Copper deficiency anemia: Review article. Ann Hematol.
97:1527–1534. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gromadzka G, Tarnacka B, Flaga A and
Adamczyk A: Copper dyshomeostasis in neurodegenerative
diseases-therapeutic implications. Int J Mol Sci. 21:92592020.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sailer J, Nagel J, Akdogan B, Jauch AT,
Engler J, Knolle PA and Zischka H: Deadly excess copper. Redox
Biol. 75:1032562024. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang S, Huang Q, Ji T, Li Q and Hu C:
Copper homeostasis and copper-induced cell death in tumor immunity:
Implications for therapeutic strategies in cancer immunotherapy.
Biomark Res. 12:1302024. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang XR and Cull B: Apoptosis and
autophagy: Current understanding in tick-pathogen interactions.
Front Cell Infect Microbiol. 12:7844302022. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hong Y, He J, Deng D, Liu Q, Zu X and Shen
Y: Targeting kinases that regulate programmed cell death: A new
therapeutic strategy for breast cancer. J Transl Med. 23:4392025.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bertheloot D, Latz E and Franklin BS:
Necroptosis, pyroptosis and apoptosis: An intricate game of cell
death. Cell Mol Immunol. 18:1106–1121. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gao W, Wang X, Zhou Y, Wang X and Yu Y:
Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor
immunotherapy. Signal Transduct Target Ther. 7:1962022. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rao Z, Zhu Y, Yang P, Chen Z, Xia Y, Qiao
C, Liu W, Deng H, Li J, Ning P and Wang Z: Pyroptosis in
inflammatory diseases and cancer. Theranostics. 12:4310–4329. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jiang X, Stockwell BR and Conrad M:
Ferroptosis: Mechanisms, biology and role in disease. Nat Rev Mol
Cell Biol. 22:266–282. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Debnath J, Gammoh N and Ryan KM: Autophagy
and autophagy-related pathways in cancer. Nat Rev Mol Cell Biol.
24:560–575. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tsvetkov P, Coy S, Petrova B, Dreishpoon
M, Verma A, Abdusamad M, Rossen J, Joesch-Cohen L, Humeidi R,
Spangler RD, et al: Copper induces cell death by targeting
lipoylated TCA cycle proteins. Science. 375:1254–1261. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhao G, Sun H, Zhang T and Liu JX: Copper
induce zebrafish retinal developmental defects via triggering
stresses and apoptosis. Cell Commun Signal. 18:452020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ostrakhovitch EA and Cherian MG: Role of
p53 and reactive oxygen species in apoptotic response to copper and
zinc in epithelial breast cancer cells. Apoptosis. 10:111–121.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li Y, Du Y, Zhou Y, Chen Q, Luo Z, Ren Y,
Chen X and Chen G: Iron and copper: Critical executioners of
ferroptosis, cuproptosis and other forms of cell death. Cell Commun
Signal. 21:3272023. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Vana F, Szabo Z, Masarik M and
Kratochvilova M: The interplay of transition metals in ferroptosis
and pyroptosis. Cell Div. 19:242024. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xue Q, Yan D, Chen X, Li X, Kang R,
Klionsky DJ, Kroemer G, Chen X, Tang D and Liu J: Copper-dependent
autophagic degradation of GPX4 drives ferroptosis. Autophagy.
19:1982–1996. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fu Y, Zeng S, Wang Z, Huang H, Zhao X and
Li M: Mechanisms of copper-induced autophagy and links with human
diseases. Pharmaceuticals (Basel). 18:992025. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xue Q, Kang R, Klionsky DJ, Tang D, Liu J
and Chen X: Copper metabolism in cell death and autophagy.
Autophagy. 19:2175–2195. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang Y, Qiao S, Wang P, Li M, Ma X, Wang H
and Dong J: Copper's new role in cancer: How cuproptosis-related
genes could revolutionize glioma treatment. BMC Cancer. 25:8592025.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tang X, Yan Z, Miao Y, Ha W, Li Z, Yang L
and Mi D: Copper in cancer: From limiting nutrient to therapeutic
target. Front Oncol. 13:12091562023. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shoda K, Kawaguchi Y, Maruyama S and
Ichikawa D: Essential updates 2023/2024: Recent advances of
multimodal approach in patients for gastric cancer. Ann
Gastroenterol Surg. 9:1119–1127. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ricci AD, Rizzo A and Brandi G: DNA damage
response alterations in gastric cancer: knocking down a new wall.
Future Oncol. 17:865–868. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Rizzo A and Ricci AD: Challenges and
future trends of hepatocellular carcinoma immunotherapy. Int J Mol
Sci. 23:113632022. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Vitale E, Rizzo A, Santa K and Jirillo E:
Associations between 'Cancer Risk', 'Inflammation' and 'Metabolic
Syndrome': A scoping review. Biology (Basel). 13:3522024.
|
|
33
|
Brandi G, Ricci AD, Rizzo A, Zanfi C,
Tavolari S, Palloni A, De Lorenzo S, Ravaioli M and Cescon M: Is
post-transplant chemotherapy feasible in liver transplantation for
colorectal cancer liver metastases? Cancer Commun (Lond).
40:461–464. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mason KE: A conspectus of research on
copper metabolism and requirements of man. J Nutr. 109:1979–2066.
1979. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Eisses JF and Kaplan JH: The mechanism of
copper uptake mediated by human CTR1: A mutational analysis. J Biol
Chem. 280:37159–37168. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zischka H and Einer C: Mitochondrial
copper homeostasis and its derailment in Wilson disease. Int J
Biochem Cell Biol. 102:71–75. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Jiayi H, Ziyuan T, Tianhua X, Mingyu Z,
Yutong M, Jingyu W, Hongli Z and Li S: Copper homeostasis in
chronic kidney disease and its crosstalk with ferroptosis.
Pharmacol Res. 202:1071392024. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chen J, Jiang Y, Shi H, Peng Y, Fan X and
Li C: The molecular mechanisms of copper metabolism and its roles
in human diseases. Pflugers Arch. 472:1415–1429. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lutsenko S: Dynamic and cell-specific
transport networks for intracellular copper ions. J Cell Sci.
134:jcs2405232021. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
McKie AT, Barrow D, Latunde-Dada GO, Rolfs
A, Sager G, Mudaly E, Mudaly M, Richardson C, Barlow D, Bomford A,
et al: An iron-regulated ferric reductase associated with the
absorption of dietary iron. Science. 291:1755–1759. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Mastrogiannaki M, Matak P, Keith B, Simon
MC, Vaulont S and Peyssonnaux C: HIF-2alpha, but not HIF-1alpha,
promotes iron absorption in mice. J Clin Invest. 119:1159–1166.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kawamata H and Manfredi G: Import,
maturation, and function of SOD1 and its copper chaperone CCS in
the mitochondrial intermembrane space. Antioxid Redox Signal.
13:1375–1384. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wang Z, Jin D, Zhou S, Dong N, Ji Y, An P,
Wang J, Luo Y and Luo J: Regulatory roles of copper metabolism and
cuproptosis in human cancers. Front Oncol. 13:11234202023.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ohrvik H and Thiele DJ: How copper
traverses cellular membranes through the mammalian copper
transporter 1, Ctr1. Ann N Y Acad Sci. 1314:32–41. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yu Q, Xiao Y, Guan M, Zhang X, Yu J, Han M
and Li Z: Copper metabolism in osteoarthritis and its relation to
oxidative stress and ferroptosis in chondrocytes. Front Mol Biosci.
11:14724922024. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kim H, Wu X and Lee J: SLC31 (CTR) family
of copper transporters in health and disease. Mol Aspects Med.
34:561–570. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Cobine PA, Moore SA and Leary SC: Getting
out what you put in: Copper in mitochondria and its impacts on
human disease. Biochim Biophys Acta Mol Cell Res. 1868:1188672021.
View Article : Google Scholar
|
|
48
|
Chen Z, Li YY and Liu X: Copper
homeostasis and copper-induced cell death: Novel targeting for
intervention in the pathogenesis of vascular aging. Biomed
Pharmacother. 169:1158392023. View Article : Google Scholar
|
|
49
|
Andersson M, Mattle D, Sitsel O, Klymchuk
T, Nielsen AM, Moller LB, White SH, Nissen P and Gourdon P:
Copper-transporting P-type ATPases use a unique ion-release
pathway. Nat Struct Mol Biol. 21:43–48. 2014. View Article : Google Scholar :
|
|
50
|
Telianidis J, Hung YH, Materia S and
Fontaine SL: Role of the P-Type ATPases, ATP7A and ATP7B in brain
copper homeostasis. Front Aging Neurosci. 5:442013. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Fanni D, Pilloni L, Orru S, Coni P,
Liguori C, Serra S, Lai ML, Uccheddu A, Contu L, Van Eyken P and
Faa G: Expression of ATP7B in normal human liver. Eur J Histochem.
49:371–378. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
52
|
Kaler SG: ATP7A-related copper transport
diseases-emerging concepts and future trends. Nat Rev Neurol.
7:15–29. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Yang GM, Xu L, Wang RM, Tao X, Zheng ZW,
Chang S, Ma D, Zhao C, Dong Y, Wu S, et al: Structures of the human
Wilson disease copper transporter ATP7B. Cell Rep. 42:1124172023.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Fukai T, Ushio-Fukai M and Kaplan JH:
Copper transporters and copper chaperones: Roles in cardiovascular
physiology and disease. Am J Physiol Cell Physiol. 315:C186–C201.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Ugarte M, Osborne NN, Brown LA and Bishop
PN: Iron, zinc, and copper in retinal physiology and disease. Surv
Ophthalmol. 58:585–609. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Ishida S, Andreux P, Poitry-Yamate C,
Auwerx J and Hanahan D: Bioavailable copper modulates oxidative
phosphorylation and growth of tumors. Proc Natl Acad Sci USA.
110:19507–19512. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Wooton-Kee CR, Robertson M, Zhou Y, Dong
B, Sun Z, Kim KH, Liu H, Xu Y, Putluri N, Saha P, et al: Metabolic
dysregulation in the Atp7b(-/-) Wilson's disease mouse model. Proc
Natl Acad Sci USA. 117:2076–2083. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Yang H, Ralle M, Wolfgang MJ, Dhawan N,
Burkhead JL, Rodriguez S, Kaplan JH, Wong GW, Haughey N and
Lutsenko S: Copper-dependent amino oxidase 3 governs selection of
metabolic fuels in adipocytes. PLoS Biol. 16:e20065192018.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Kim E, Chufan EE, Kamaraj K and Karlin KD:
Synthetic models for heme-copper oxidases. Chem Rev. 104:1077–1133.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Anwar S, Sarwar T, Khan AA and Rahmani AH:
Therapeutic applications and mechanisms of superoxide dismutase
(SOD) in different pathogenesis. Biomolecules. 15:11302025.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Grubman A and White AR: Copper as a key
regulator of cell signalling pathways. Expert Rev Mol Med.
16:e112014. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Heffern MC, Park HM, Au-Yeung HY, Van de
Bittner GC, Ackerman CM, Stahl A and Chang CJ: In vivo
bioluminescence imaging reveals copper deficiency in a murine model
of nonalcoholic fatty liver disease. Proc Natl Acad Sci USA.
113:14219–14224. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Herranz N, Dave N, Millanes-Romero A,
Morey L, Diaz VM, Lorenz-Fonfria V, Gutierrez-Gallego R, Jerónimo
C, Di Croce L, García de Herreros A and Peiró S: Lysyl oxidase-like
2 deaminates lysine 4 in histone H3. Mol Cell. 46:369–376. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Percival SS: Copper and immunity. Am J
Clin Nutr. 67(5 Suppl): 1064S–1068S. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
An Y, Li S, Huang X, Chen X, Shan H and
Zhang M: The role of copper homeostasis in brain disease. Int J Mol
Sci. 23:138502022. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Cheng YF, Zhao YJ, Chen C and Zhang F:
Heavy metals toxicity: Mechanism, health effects, and therapeutic
interventions. MedComm (2020). 6:e702412025. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Zheng P, Zhou C, Lu L, Liu B and Ding Y:
Elesclomol: A copper ionophore targeting mitochondrial metabolism
for cancer therapy. J Exp Clin Cancer Res. 41:2712022. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Kong R and Sun G: Targeting copper
metabolism: A promising strategy for cancer treatment. Front
Pharmacol. 14:12034472023. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Nan L, Yuan W, Guodong C and Yonghui H:
Multitargeting strategy using tetrathiomolybdate and lenvatinib:
Maximizing antiangiogenesis activity in a preclinical liver cancer
model. Anticancer Agents Med Chem. 23:786–793. 2023. View Article : Google Scholar
|
|
70
|
Cohen R, Raeisi M, Chibaudel B, Yothers G,
Goldberg RM, Bachet JB, Wolmark N, Yoshino T, Schmoll HJ, Haller
DG, et al: Impact of tumor and node stages on the efficacy of
adjuvant oxaliplatin-based chemotherapy in stage III colon cancer
patients: An ACCENT pooled analysis. ESMO Open. 10:1044812025.
View Article : Google Scholar
|
|
71
|
Nawar MF and Turler A: New strategies for
a sustainable (99m) Tc supply to meet increasing medical demands:
Promising solutions for current problems. Front Chem.
10:9262582022. View Article : Google Scholar
|
|
72
|
Wang W, Mo W, Hang Z, Huang Y, Yi H, Sun Z
and Lei A: Cuproptosis: Harnessing transition metal for cancer
therapy. ACS Nano. 17:19581–19599. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Ge EJ, Bush AI, Casini A, Cobine PA, Cross
JR, DeNicola GM, Dou QP, Franz KJ, Gohil VM, Gupta S, et al:
Connecting copper and cancer: From transition metal signalling to
metalloplasia. Nat Rev Cancer. 22:102–113. 2022. View Article : Google Scholar :
|
|
74
|
Li Y: Copper homeostasis: Emerging target
for cancer treatment. IUBMB Life. 72:1900–1908. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Cong Y, Li N, Zhang Z, Shang Y and Zhao H:
Cuproptosis: Molecular mechanisms, cancer prognosis, and
therapeutic applications. J Transl Med. 23:1042025. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Shim D and Han J: Coordination chemistry
of mitochondrial copper metalloenzymes: Exploring implications for
copper dyshomeostasis in cell death. BMB Rep. 56:575–583. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Cheng H, Yang B, Ke T, Li S, Yang X,
Aschner M and Chen P: Mechanisms of metal-induced mitochondrial
dysfunction in neurological disorders. Toxics. 9:1422021.
View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Tsvetkov P, Detappe A, Cai K, Keys HR,
Brune Z, Ying W, Thiru P, Reidy M, Kugener G, Rossen J, et al:
Mitochondrial metabolism promotes adaptation to proteotoxic stress.
Nat Chem Biol. 15:681–689. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Sun L, Zhang Y, Yang B, Sun S, Zhang P,
Luo Z, Feng T, Cui Z, Zhu T, Li Y, et al: Lactylation of METTL16
promotes cuproptosis via m(6)A-modification on FDX1 mRNA in gastric
cancer. Nat Commun. 14:65232023. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Polishchuk EV, Concilli M, Iacobacci S,
Chesi G, Pastore N, Piccolo P, Paladino S, Baldantoni D, van
IJzendoorn SC, Chan J, et al: Wilson disease protein ATP7B utilizes
lysosomal exocytosis to maintain copper homeostasis. Dev Cell.
29:686–700. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Yang L, Zhang Y, Wang Y, Jiang P, Liu F
and Feng N: Ferredoxin 1 is a cuproptosis-key gene responsible for
tumor immunity and drug sensitivity: A pan-cancer analysis. Front
Pharmacol. 13:9381342022. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Sheftel AD, Stehling O, Pierik AJ,
Elsasser HP, Muhlenhoff U, Webert H, Hobler A, Hannemann F,
Bernhardt R and Lill R: Humans possess two mitochondrial
ferredoxins, Fdx1 and Fdx2, with distinct roles in steroidogenesis,
heme, and Fe/S cluster biosynthesis. Proc Natl Acad Sci USA.
107:11775–11780. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Huang X, Wang T, Ye J, Feng H and Zhang X,
Ma X, Wang B, Huang Y and Zhang X: FDX1 expression predicts
favourable prognosis in clear cell renal cell carcinoma identified
by bioinformatics and tissue microarray analysis. Front Genet.
13:9947412022. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Mayr JA, Zimmermann FA, Fauth C, Bergheim
C, Meierhofer D, Radmayr D, Zschocke J, Koch J and Sperl W: Lipoic
acid synthetase deficiency causes neonatal-onset epilepsy,
defective mitochondrial energy metabolism, and glycine elevation.
Am J Hum Genet. 89:792–797. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Cai Y, He Q, Liu W, Liang Q, Peng B, Li J,
Zhang W, Kang F, Hong Q, Yan Y, et al: Comprehensive analysis of
the potential cuproptosis-related biomarker LIAS that regulates
prognosis and immunotherapy of pan-cancers. Front Oncol.
12:9521292022. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Casteel J, Miernyk JA and Thelen JJ:
Mapping the lipoylation site of Arabidopsis thaliana plastidial
dihydrolipoamide S-acetyltransferase using mass spectrometry and
site-directed mutagenesis. Plant Physiol Biochem. 49:1355–1361.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Rumping L, Tessadori F, Pouwels PJW,
Vringer E, Wijnen JP, Bhogal AA, Savelberg SMC, Duran KJ, Bakkers
MJG, Ramos RJJ, et al: GLS hyperactivity causes glutamate excess,
infantile cataract and profound developmental delay. Hum Mol Genet.
28:96–104. 2019. View Article : Google Scholar
|
|
88
|
Rumping L, Buttner B, Maier O, Rehmann H,
Lequin M, Schlump JU, Schmitt B, Schiebergen-Bronkhorst B, Prinsen
HCMT, Losa M, et al: Identification of a loss-of-function mutation
in the context of glutaminase deficiency and neonatal epileptic
encephalopathy. JAMA Neurol. 76:342–350. 2019. View Article : Google Scholar :
|
|
89
|
Agarwal P, Sandey M, DeInnocentes P and
Bird RC: Tumor suppressor gene p16/INK4A/CDKN2A-dependent
regulation into and out of the cell cycle in a spontaneous canine
model of breast cancer. J Cell Biochem. 114:1355–1363. 2013.
View Article : Google Scholar
|
|
90
|
Serrano M, Hannon GJ and Beach D: A new
regulatory motif in cell-cycle control causing specific inhibition
of cyclin D/CDK4. Nature. 366:704–407. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Bian Z, Yu Y, Yang T, Quan C, Sun W and Fu
S: Effect of tumor suppressor gene cyclin-dependent kinase
inhibitor 2A wild-type and A148T mutant on the cell cycle of human
ovarian cancer cells. Oncol Lett. 7:1229–1232. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Samimi G, Safaei R, Katano K, Holzer AK,
Rochdi M, Tomioka M, Goodman M and Howell SB: Increased expression
of the copper efflux transporter ATP7A mediates resistance to
cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells.
Clin Cancer Res. 10:4661–4669. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Tian Z, Jiang S, Zhou J and Zhang W:
Copper homeostasis and cuproptosis in mitochondria. Life Sci.
334:1222232023. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Mangala LS, Zuzel V, Schmandt R, Leshane
ES, Halder JB, Armaiz-Pena GN, Spannuth WA, Tanaka T, Shahzad MM,
Lin YG, et al: Therapeutic targeting of ATP7B in ovarian carcinoma.
Clin Cancer Res. 15:3770–3780. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Yun Y, Wang Y, Yang E and Jing X:
Cuproptosis-related gene - SLC31A1, FDX1 and ATP7B-polymorphisms
are associated with risk of lung cancer. Pharmgenomics Pers Med.
15:733–742. 2022.
|
|
96
|
Wang D, Tian Z, Zhang P, Zhen L, Meng Q,
Sun B, Xu X, Jia T and Li S: The molecular mechanisms of
cuproptosis and its relevance to cardiovascular disease. Biomed
Pharmacother. 163:1148302023. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Halliwell B, Adhikary A, Dingfelder M and
Dizdaroglu M: Hydroxyl radical is a significant player in oxidative
DNA damage in vivo. Chem Soc Rev. 50:8355–8360. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Chandimali N, Bak SG, Park EH, Lim HJ, Won
YS, Kim EK, Park SI and Lee SJ: Free radicals and their impact on
health and antioxidant defenses: A review. Cell Death Discov.
11:192025. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Wong-Ekkabut J, Xu Z, Triampo W, Tang IM,
Tieleman DP and Monticelli L: Effect of lipid peroxidation on the
properties of lipid bilayers: A molecular dynamics study. Biophys
J. 93:4225–4236. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Kehm R, Baldensperger T, Raupbach J and
Höhn A: Protein oxidation - Formation mechanisms, detection and
relevance as biomarkers in human diseases. Redox Biol.
42:1019012021. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Vo TTT, Peng TY, Nguyen TH, Bui TNH, Wang
CS, Lee WJ, Chen YL, Wu YC and Lee IT: The crosstalk between
copper-induced oxidative stress and cuproptosis: A novel potential
anticancer paradigm. Cell Commun Signal. 22:3532024. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Chen W, Jiang T, Wang H, Tao S, Lau A,
Fang D and Zhang DD: Does Nrf2 contribute to p53-mediated control
of cell survival and death? Antioxid Redox Signal. 17:1670–1675.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Shan D, Song J, Ren Y, Zhang Y, Ba Y, Luo
P, Cheng Q, Xu H, Weng S, Zuo A, et al: Copper in cancer: Friend or
foe? Metabolism, dysregulation, and therapeutic opportunities.
Cancer Commun (Lond). 45:577–607. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Dow JA: The essential roles of metal ions
in insect homeostasis and physiology. Curr Opin Insect Sci.
23:43–50. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Ding X, Jiang M, Jing H, Sheng W, Wang X,
Han J and Wang L: Analysis of serum levels of 15 trace elements in
breast cancer patients in Shandong, China. Environ Sci Pollut Res
Int. 22:7930–7935. 2015. View Article : Google Scholar
|
|
106
|
Kuo HW, Chen SF, Wu CC, Chen DR and Lee
JH: Serum and tissue trace elements in patients with breast cancer
in Taiwan. Biol Trace Elem Res. 89:1–11. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Pavithra V, Sathisha TG, Kasturi K,
Mallika DS, Amos SJ and Ragunatha S: Serum levels of metal ions in
female patients with breast cancer. J Clin Diagn Res. 9:BC25–c27.
2015.PubMed/NCBI
|
|
108
|
Feng JF, Lu L, Zeng P, Yang YH, Luo J,
Yang YW and Wang D: Serum total oxidant/antioxidant status and
trace element levels in breast cancer patients. Int J Clin Oncol.
17:575–583. 2012. View Article : Google Scholar
|
|
109
|
Zowczak M, Iskra M, Torlinski L and Cofta
S: Analysis of serum copper and zinc concentrations in cancer
patients. Biol Trace Elem Res. 82:1–8. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Diez M, Cerdan FJ, Arroyo M and Balibrea
JL: Use of the copper/zinc ratio in the diagnosis of lung cancer.
Cancer. 63:726–730. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Jin Y, Zhang C, Xu H, Xue S, Wang Y, Hou
Y, Kong Y and Xu Y: Combined effects of serum trace metals and
polymorphisms of CYP1A1 or GSTM1 on non-small cell lung cancer: A
hospital based case-control study in China. Cancer Epidemiol.
35:182–187. 2011. View Article : Google Scholar
|
|
112
|
Oyama T, Matsuno K, Kawamoto T, Mitsudomi
T, Shirakusa T and Kodama Y: Efficiency of serum copper/zinc ratio
for differential diagnosis of patients with and without lung
cancer. Biol Trace Elem Res. 42:115–127. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Stepien M, Jenab M, Freisling H, Becker
NP, Czuban M, Tjonneland A, Olsen A, Overvad K, Boutron-Ruault MC,
Mancini FR, et al: Pre-diagnostic copper and zinc biomarkers and
colorectal cancer risk in the European Prospective Investigation
into Cancer and Nutrition cohort. Carcinogenesis. 38:699–707. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Sohrabi M, Gholami A, Azar MH, Yaghoobi M,
Shahi MM, Shirmardi S, Nikkhah M, Kohi Z, Salehpour D, Khoonsari
MR, et al: Trace element and heavy metal levels in colorectal
cancer: Comparison between cancerous and non-cancerous tissues.
Biol Trace Elem Res. 183:1–8. 2018. View Article : Google Scholar
|
|
115
|
Margalioth EJ, Schenker JG and Chevion M:
Copper and zinc levels in normal and malignant tissues. Cancer.
52:868–872. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Yaman M, Kaya G and Yekeler H:
Distribution of trace metal concentrations in paired cancerous and
non-cancerous human stomach tissues. World J Gastroenterol.
13:612–618. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Khanna SS and Karjodkar FR: Circulating
immune complexes and trace elements (Copper, Iron and Selenium) as
markers in oral precancer and cancer: A randomised, controlled
clinical trial. Head Face Med. 2:332006. View Article : Google Scholar
|
|
118
|
Baltaci AK, Dundar TK, Aksoy F and
Mogulkoc R: Changes in the serum levels of trace elements before
and after the operation in thyroid cancer patients. Biol Trace Elem
Res. 175:57–64. 2017. View Article : Google Scholar
|
|
119
|
Basu S, Singh MK, Singh TB, Bhartiya SK,
Singh SP and Shukla VK: Heavy and trace metals in carcinoma of the
gallbladder. World J Surg. 37:2641–2646. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Saleh SAK, Adly HM, Abdelkhaliq AA and
Nassir AM: Serum levels of selenium, zinc, copper, manganese, and
iron in prostate cancer patients. Curr Urol. 14:44–49. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Blockhuys S, Celauro E, Hildesjo C, Feizi
A, Stal O, Fierro-Gonzalez JC and Wittung-Stafshede P: Defining the
human copper proteome and analysis of its expression variation in
cancers. Metallomics. 9:112–123. 2017. View Article : Google Scholar
|
|
122
|
Wang W, Lu K, Jiang X, Wei Q, Zhu L, Wang
X, Jin H and Feng L: Ferroptosis inducers enhanced cuproptosis
induced by copper ionophores in primary liver cancer. J Exp Clin
Cancer Res. 42:1422023. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Harris ED: A Requirement for Copper in
Angiogenesis. Nutr Rev. 62:60–64. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
De Luca A, Barile A, Arciello M and Rossi
L: Copper homeostasis as target of both consolidated and innovative
strategies of anti-tumor therapy. J Trace Elem Med Biol.
55:204–213. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Barker HE, Cox TR and Erler JT: The
rationale for targeting the LOX family in cancer. Nat Rev Cancer.
12:540–552. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Groleau J, Dussault S, Haddad P, Turgeon
J, Menard C, Chan JS and Rivard A: Essential role of copper-zinc
superoxide dismutase for ischemia-induced neovascularization via
modulation of bone marrow-derived endothelial progenitor cells.
Arterioscler Thromb Vasc Biol. 30:2173–2181. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Lowndes SA and Harris AL: Copper chelation
as an antiangiogenic therapy. Oncol Res. 14:529–539. 2004.
View Article : Google Scholar
|
|
128
|
Pannecoeck R, Serruys D, Benmeridja L,
Delanghe JR, van Geel N, Speeckaert R and Speeckaert MM: Vascular
adhesion protein-1: Role in human pathology and application as a
biomarker. Crit Rev Clin Lab Sci. 52:284–300. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Wong CC, Tse AP, Huang YP, Zhu YT, Chiu
DK, Lai RK, Au SL, Kai AK, Lee JM, Wei LL, et al: Lysyl
oxidase-like 2 is critical to tumor microenvironment and metastatic
niche formation in hepatocellular carcinoma. Hepatology.
60:1645–1658. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Salvador F, Martin A, Lopez-Menendez C,
Moreno-Bueno G, Santos V, Vazquez-Naharro A, Santamaria PG, Morales
S, Dubus PR, Muinelo-Romay L, et al: Lysyl oxidase-like protein
LOXL2 promotes lung metastasis of breast cancer. Cancer Res.
77:5846–5859. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Cheng F, Peng G, Lu Y, Wang K, Ju Q, Ju Y
and Ouyang M: Relationship between copper and immunity: The
potential role of copper in tumor immunity. Front Oncol.
12:10191532022. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Kang J, Lin C, Chen J and Liu Q: Copper
induces histone hypoacetylation through directly inhibiting histone
acetyltransferase activity. Chem Biol Interact. 148:115–123. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
133
|
International Agency for Research on
Cancer: Oesophageal cancer. GLOBOCAN. 2022, https://www.iarc.who.int/cancer-type/oesophageal-cancer/.
Accessed Dec 2, 2025
|
|
134
|
Zhang Y, Liu S, Zhou S, Yu D, Gu J, Qin Q,
Cheng Y and Sun X: Focal adhesion kinase: Insight into its roles
and therapeutic potential in oesophageal cancer. Cancer Lett.
496:93–103. 2021. View Article : Google Scholar
|
|
135
|
Liu XS, Yuan LL, Gao Y, Zhou LM, Yang JW
and Pei ZJ: Overexpression of METTL3 associated with the metabolic
status on (18)F-FDG PET/CT in patients with esophageal carcinoma. J
Cancer. 11:4851–4860. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Liu XS, Zhang Y, Liu ZY, Gao Y, Yuan LL,
Zeng DB, Tan F, Wan HB and Pei ZJ: METTL3 as a novel diagnosis and
treatment biomarker and its association with glycolysis,
cuproptosis and ceRNA in oesophageal carcinoma. J Cell Mol Med.
28:e181952024. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Lin K, Hu K, Chen Q and Wu J: The function
and immune role of cuproptosis associated hub gene in Barrett's
esophagus and esophageal adenocarcinoma. Biosci Trends. 17:381–392.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Bas O, Sahin TK, Karahan L, Rizzo A and
Guven DC: Prognostic significance of the cachexia index (CXI) in
patients with cancer: A systematic review and meta-analysis. Clin
Nutr ESPEN. 68:240–247. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
International Agency for Research on
Cancer: Stomach cancer. GLOBOCAN. 2022, https://www.iarc.who.int/cancer-type/stomach-cancer/.
Accessed Dec 2, 2025
|
|
140
|
Wang H, Liu M, Zeng X, Zheng Y, Wang Y and
Zhou Y: Cell death affecting the progression of gastric cancer.
Cell Death Discov. 8:3772022. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Song Q, Liu S, Wu D and Cai A: Multiple
programmed cell death patterns predict the prognosis and drug
sensitivity in gastric cancer. Front Immunol. 16:15114532025.
View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Li Y, Sun W, Yuan S, Liu X, Zhang Z, Gu R,
Li P and Gu X: The role of cuproptosis in gastric cancer. Front
Immunol. 15:14356512024. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Zhou Y, Dong C, Shen X, Wang P, Chen T, Li
W, Sun X, Li P, Xu C, Duan K, et al: Targeting PTBP3-Mediated
alternative splicing of COX11 induces cuproptosis for inhibiting
gastric cancer peritoneal metastasis. Adv Sci (Weinh).
12:e24159832025. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Zuo X, Lei Y, Ou S, Yuan X, Shi P, Li Q
and Xu Y: Integration of cuproptosis-related gene signatures in
stomach adenocarcinoma: Implications for prognostic prediction and
therapeutic strategies in cancer drug resistance. Discov Oncol.
16:8852025. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Xie XZ, Zuo L, Huang W, Fan QM, Weng YY,
Yao WD, Jiang JL and Jin JQ: FDX1 as a novel biomarker and
treatment target for stomach adenocarcinoma. World J Gastrointest
Surg. 16:1803–1824. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Lu L, Yang W, Gu Y, Jin L and Liang Z: The
role of cuproptosis in the occurrence and development of gastric
cancer. Front Pharmacol. 16:16642002025. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Chen Y, Liao Y, Huang L and Luo Z:
Exploring copper metabolism-induced cell death in gastric cancer: A
single-cell RNA sequencing study and prognostic model development.
Discov Oncol. 15:4822024. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
International Agency for Research on
Cancer: Liver cancer. GLOBOCAN. 2022, https://www.iarc.who.int/cancer-type/liver-cancer/.
Accessed Dec 2, 2025
|
|
149
|
Yu M, Chen Z, Zhou Q, Zhang B, Huang J,
Jin L, Zhou B, Liu S, Yan J, Li X, et al: PARG inhibition limits
HCC progression and potentiates the efficacy of immune checkpoint
therapy. J Hepatol. 77:140–151. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Huang H, Tsui YM and Ng IO: Fueling HCC
dynamics: Interplay between tumor microenvironment and tumor
initiating cells. Cell Mol Gastroenterol Hepatol. 15:1105–1116.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Fang AP, Chen PY, Wang XY, Liu ZY, Zhang
DM, Luo Y, Liao GC, Long JA, Zhong RH, Zhou ZG, et al: Serum copper
and zinc levels at diagnosis and hepatocellular carcinoma survival
in the Guangdong liver cancer cohort. Int J Cancer. 144:2823–2832.
2019. View Article : Google Scholar
|
|
152
|
Gunjan D, Shalimar, Nadda N, Kedia S,
Nayak B, Paul SB, Gamanagatti SR and Acharya SK: Hepatocellular
carcinoma: An unusual complication of longstanding wilson disease.
J Clin Exp Hepatol. 7:152–154. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Haratake J, Horie A and Takeda S:
Histochemical and ultrastructural study of copper-binding protein
in hepatocellular carcinoma. Cancer. 60:1269–1274. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Lefkowitch JH, Muschel R, Price JB, Marboe
C and Braunhut S: Copper and copper-binding protein in
fibrolamellar liver cell carcinoma. Cancer. 51:97–100. 1983.
View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Davis CI, Gu X, Kiefer RM, Ralle M, Gade
TP and Brady DC: Altered copper homeostasis underlies sensitivity
of hepatocellular carcinoma to copper chelation. Metallomics.
12:1995–2008. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Poznanski J, Soldacki D, Czarkowska-Paczek
B, Bonna A, Kornasiewicz O, Krawczyk M, Bal W and Pączek L:
Cirrhotic liver of liver transplant recipients accumulate silver
and co-accumulate copper. Int J Mol Sci. 22:17822021. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Li Z, Zhou H, Zhai X, Gao L, Yang M, An B,
Xia T, Du G, Li X, Wang W and Jin B: MELK promotes HCC
carcinogenesis through modulating cuproptosis-related gene
DLAT-mediated mitochondrial function. Cell Death Dis. 14:7332023.
View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Guo J, Cheng J, Zheng N, Zhang X, Dai X,
Zhang L, Hu C, Wu X, Jiang Q, Wu D, et al: Copper promotes
tumorigenesis by activating the PDK1-AKT oncogenic pathway in a
copper transporter 1 dependent manner. Adv Sci (Weinh).
8:e20043032021. View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Quan B, Liu W, Yao F, Li M, Tang B, Li J,
Ren Z and Yin X: LINC02362/hsa-miR-18a-5p/FDX1 axis suppresses
proliferation and drives cuproptosis and oxaliplatin sensitivity of
hepatocellular carcinoma. Am J Cancer Res. 13:5590–5609.
2023.PubMed/NCBI
|
|
160
|
Oliveri V: Selective targeting of cancer
cells by copper ionophores: An overview. Front Mol Biosci.
9:8418142022. View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Zhou C, Yang J, Liu T, Jia R, Yang L, Sun
P and Zhao W: Copper metabolism and hepatocellular carcinoma:
Current insights. Front Oncol. 13:11866592023. View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Zhao X, Chen J, Yin S, Shi J, Zheng M, He
C, Meng H, Han Y, Han J, Guo J, et al: The expression of
cuproptosis-related genes in hepatocellular carcinoma and their
relationships with prognosis. Front Oncol. 12:9924682022.
View Article : Google Scholar : PubMed/NCBI
|
|
163
|
International Agency for Research on
Cancer: Pancreatic cancer. GLOBOCAN. 2022, https://www.iarc.who.int/cancer-type/pancreatic-cancer/.
Accessed Dec 2, 2025
|
|
164
|
Leiphrakpam PD, Chowdhury S, Zhang M,
Bajaj V, Dhir M and Are C: Trends in the global incidence of
pancreatic cancer and a brief review of its histologic and
molecular subtypes. J Gastrointest Cancer. 56:712025. View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Lener MR, Scott RJ, Wiechowska-Kozlowska
A, Serrano-Fernandez P, Baszuk P, Jaworska-Bieniek K, Sukiennicki
G, Marciniak W, Muszyńska M, Kładny J, et al: Serum concentrations
of selenium and copper in patients diagnosed with pancreatic
cancer. Cancer Res Treat. 48:1056–1064. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Gao S, Ge H, Gao L, Gao Y, Tang S, Li Y,
Yuan Z and Chen W: Silk fibroin nanoparticles for enhanced
cuproptosis and immunotherapy in pancreatic cancer treatment. Adv
Sci (Weinh). 12:e24176762025. View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Zhou C, Yi C, Yi Y, Qin W, Yan Y, Dong X,
Zhang X, Huang Y, Zhang R, Wei J, et al: LncRNA PVT1 promotes
gemcitabine resistance of pancreatic cancer via activating
Wnt/β-catenin and autophagy pathway through modulating the
miR-619-5p/Pygo2 and miR-619-5p/ATG14 axes. Mol Cancer. 19:1182020.
View Article : Google Scholar
|
|
168
|
Sun Y, Yao L, Man C, Gao Z, He R and Fan
Y: Development and validation of cuproptosis-related lncRNAs
associated with pancreatic cancer immune microenvironment based on
single-cell. Front Immunol. 14:12207602023. View Article : Google Scholar : PubMed/NCBI
|
|
169
|
International Agency for Research on
Cancer: Colorectal cancer. GLOBOCAN. 2022, https://www.iarc.who.int/cancer-type/colorectal-cancer/.
Accessed Dec 2, 2025
|
|
170
|
Yang W, Wang Y, Huang Y, Yu J, Wang T, Li
C, Yang L, Zhang P, Shi L, Yin Y, et al: 4-Octyl itaconate inhibits
aerobic glycolysis by targeting GAPDH to promote cuproptosis in
colorectal cancer. Biomed Pharmacother. 159:1143012023. View Article : Google Scholar : PubMed/NCBI
|
|
171
|
Gu Y, Li C, Yan Y, Ming J, Li Y, Chao X
and Wang T: Comprehensive analysis and verification of the
prognostic significance of cuproptosis-related genes in colon
adenocarcinoma. Int J Mol Sci. 25:118302024. View Article : Google Scholar : PubMed/NCBI
|
|
172
|
Ma J, Lin H, Wang Y, Zhang Y, Zhou C, Tang
D, Kagawa Y, Hou D and Jiang G: The unique role of cuproptosis in
the prognosis and treatment of rectum adenocarcinoma. J
Gastrointest Oncol. 16:367–385. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
173
|
Wang Y, Pei P, Yang K, Guo L and Li Y:
Copper in colorectal cancer: From copper-related mechanisms to
clinical cancer therapies. Clin Transl Med. 14:e17242024.
View Article : Google Scholar : PubMed/NCBI
|
|
174
|
Li Y, Chen F, Chen J, Chan S, He Y, Liu W
and Zhang G: Disulfiram/Copper induces antitumor activity against
both nasopharyngeal cancer cells and cancer-associated fibroblasts
through ROS/MAPK and ferroptosis pathways. Cancers (Basel).
12:1382020. View Article : Google Scholar : PubMed/NCBI
|
|
175
|
Chan N, Willis A, Kornhauser N, Ward MM,
Lee SB, Nackos E, Seo BR, Chuang E, Cigler T, Moore A, et al:
Correction: Influencing the tumor microenvironment: A phase II
study of copper depletion using tetrathiomolybdate in patients with
breast cancer at high risk for recurrence and in preclinical models
of lung metastases. Clin Cancer Res. 26:50512020. View Article : Google Scholar : PubMed/NCBI
|
